LifeWave Biomedical is developing a digital health product in value-based care, called the CardioConnect® system, that improves the management of patients diagnosed with congestive heart failure (CHF) and respiratory/lung diseases in hospital, ambulatory, and home settings.

The solution consists of a small non-invasive sensor that will deliver accurate and absolute measurement of lung fluids and cardiorespiratory parameters with a brief daily assessment. The data is uploaded to a smartphone/tablet application and integrated with the patient’s drug regimen and other measured physiologic parameters to provide hospitalization decision support and to enhance patient self‑management.

The CardioConnect® integrates with a cognitive computing solution to support artificial intelligence driven analytics and the development of a population health database. The clinical and economic benefits of the CardioConnect® system are the improvement of patient quality-of-life, potential extension of life expectancy, and the reduction of health care cost associated with initial hospital admissions and re‑admissions.